The use of high resolution melting analysis to detect Fabry mutations in heterozygous females via dry bloodspots.

[1]  Shih-Jen Chen,et al.  Enzyme assay and clinical assessment in subjects with a Chinese hotspot late-onset Fabry mutation (IVS4 + 919G→A) , 2010, Journal of Inherited Metabolic Disease.

[2]  Shing‐Jong Lin,et al.  High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population , 2009, Circulation. Cardiovascular genetics.

[3]  R. Vossen,et al.  High‐Resolution Melting Analysis (HRMA)—More than just sequence variant screening , 2009, Human mutation.

[4]  Carl T Wittwer,et al.  High‐resolution DNA melting analysis: advancements and limitations , 2009, Human mutation.

[5]  E. Silverman,et al.  High-resolution melting curve analysis of genomic and whole-genome amplified DNA. , 2008, Clinical chemistry.

[6]  Karl V Voelkerding,et al.  High resolution melting applications for clinical laboratory medicine. , 2008, Experimental and molecular pathology.

[7]  J. Yagüe,et al.  Prevalence of Fabry Disease in a Cohort of 508 Unrelated Patients With Hypertrophic Cardiomyopathy , 2007 .

[8]  E. Lyon,et al.  Unlabeled oligonucleotides as internal temperature controls for genotyping by amplicon melting. , 2007, The Journal of molecular diagnostics : JMD.

[9]  Carl T Wittwer,et al.  High-resolution DNA melting analysis for simple and efficient molecular diagnostics. , 2007, Pharmacogenomics.

[10]  A. Quattrone,et al.  Gene symbol: NOTCH3. , 2007, Human genetics.

[11]  P. Bauer,et al.  Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study , 2005, The Lancet.

[12]  K. Tomita,et al.  Identification of Fabry's disease by the screening of alpha-galactosidase A activity in male and female hemodialysis patients. , 2005, Clinical nephrology.

[13]  R. Kramar,et al.  Results of a nationwide screening for Anderson-Fabry disease among dialysis patients. , 2004, Journal of the American Society of Nephrology : JASN.

[14]  C. Eng,et al.  Fabry disease: detection of undiagnosed hemodialysis patients and identification of a "renal variant" phenotype. , 2003, Kidney international.

[15]  C. N. Gundry,et al.  Amplicon melting analysis with labeled primers: a closed-tube method for differentiating homozygotes and heterozygotes. , 2003, Clinical chemistry.

[16]  P. Elliott,et al.  Prevalence of Anderson-Fabry Disease in Male Patients With Late Onset Hypertrophic Cardiomyopathy , 2002, Circulation.

[17]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[18]  P. Meikle,et al.  Prevalence of lysosomal storage disorders. , 1999, JAMA.

[19]  H. Sakuraba,et al.  An atypical variant of Fabry's disease in men with left ventricular hypertrophy. , 1995, The New England journal of medicine.

[20]  C. Eng,et al.  An atypical variant of Fabry's disease with manifestations confined to the myocardium. , 1991, The New England journal of medicine.

[21]  J. Ellison,et al.  Novel human pathological mutations. Gene symbol: PTEN. Disease: PTEN Hamartoma Tumour Syndrome. , 2010, Human Genetics.

[22]  M. A. Al Balwi,et al.  Novel human pathological mutations. Gene symbol: MAN2B1. Disease: Mannosidosis, alpha. , 2010, Human Genetics.

[23]  Carl T. Wittwer,et al.  High-Resolution Melting Curve Analysis for Molecular Diagnostics , 2010 .

[24]  Y. Chien,et al.  Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease. , 2009, Human genetics.

[25]  K. Hsiao,et al.  A novel mutation (c. 1072_1074delGAG) in the alpha-galactosidase gene of a Taiwanese family with Fabry disease. , 2004, Acta Dermato-Venereologica.

[26]  K. Hsiao,et al.  Identification of a novel point mutation (S65T) in α‐galactosidase A gene in Chinese patients with Fabry disease , 1998 .